SMS Lifesciences, a prominent player in the pharmaceutical and biotechnology industry, is headquartered in India. Founded in 2006, the company has established a strong presence in key operational regions, focusing on the development and manufacturing of active pharmaceutical ingredients (APIs) and intermediates. With a commitment to quality and innovation, SMS Lifesciences offers a diverse range of products that cater to various therapeutic areas, including oncology and cardiology. Their unique approach to research and development has positioned them as a trusted partner in the global market. Notable achievements include compliance with international regulatory standards, which underscores their dedication to excellence. As SMS Lifesciences continues to expand its footprint, it remains a vital contributor to the advancement of healthcare solutions.
How does SMS Lifesciences's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
SMS Lifesciences's score of 14 is lower than 92% of the industry. This can give you a sense of how well the company is doing compared to its peers.
SMS Lifesciences, headquartered in India, currently does not report any carbon emissions data, as there are no available figures for their Scope 1, 2, or 3 emissions. Additionally, the company has not established any specific reduction targets or climate pledges. Without emissions data or defined commitments, it is challenging to assess their climate impact or sustainability initiatives. As the industry increasingly prioritises carbon neutrality and climate action, SMS Lifesciences may need to consider developing measurable targets and strategies to align with global climate standards.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
SMS Lifesciences has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
